Alnylam Pharmaceuticals (NASDAQ:ALNY) Price Target Raised to $357.00
Alnylam Pharmaceuticals (NASDAQ:ALNY – Free Report) had its price target upped by Canaccord Genuity Group from $283.00 to $357.00 in a research report released on Monday, Benzinga reports. Canaccord Genuity Group currently has a buy rating on the biopharmaceutical company’s stock. Several other research analysts also recently commented on the company. Evercore ISI lifted their […]
More Stories
Black Doves Season 2 is Coming Soon! Release Date, Cast Members, and Production Updates
Good news! The release date for the popular spy-action drama Black Doves Season 2 is out. Keira Knightley is returning...
How to Enable AO3 Dark Mode? Sign-up and Login Process
Looking for possible ways to enable AO3 dark mode? Many readers want to read fanfiction in dark mode on Archive...
What Makes a Poolside Area Actually Comfortable to Spend Time In?
A pool can look fantastic and still have nobody sitting around it for very long. That usually has less to...
MX Player for PC: How the Android Video Player Behaves on a Desktop Screen
Most people know MX Player as the app that finally played that one weird video file their phone refused to...
Release Window for Blue Eye Samurai Season 2? Latest Updates and More
Blue Eye Samurai Season 2 is releasing soon on the most popular streaming platform, Netflix. If you are also a...
What is the Release Date for GTA 6? System Requirements and Updated Features
GTA 6 is finally arriving! After years of delays and speculation, Rockstar finally confirmed the game’s launch by the end...